FT Biotechnology 51 F RE (F00001634E)

9.929 +0.18 (+1.83%) USD  |  Jul 01 2022

F00001634E Asset Allocations & Exposures

Asset Allocation

As of June 27, 2022.
Type % Net % Long % Short
Cash 0.00% Upgrade Upgrade
Stock 100.00% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Region Exposure

% Developed Markets: 100.0% % Emerging Markets: 0.00%
Americas 89.22%
North America
 Upgrade
United States Upgrade
Latin America
 Upgrade
As of June 27, 2022. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 7.69%
United Kingdom Upgrade
Europe Developed
 Upgrade
Denmark Upgrade
Europe Emerging
 Upgrade
Africa And Middle East
 Upgrade
Greater Asia 3.09%
Japan Upgrade
Australasia
 Upgrade
Australia Upgrade
Asia Developed
 Upgrade
Asia Emerging
 Upgrade

Market Capitalization

As of June 27, 2022
Giant Upgrade
Large Upgrade
Mid Upgrade
Small Upgrade
Micro Upgrade

Stock Style Exposure

Large Cap Value Upgrade
Large Cap Blend Upgrade
Large Cap Growth Upgrade
Mid Cap Value Upgrade
Mid Cap Blend Upgrade
Mid Cap Growth Upgrade
Small Cap Value Upgrade
Small Cap Blend Upgrade
Small Cap Growth Upgrade
As of June 27, 2022

Stock Sector Exposure

Cyclical
4.49%
Basic Materials Upgrade
Consumer Cyclical Upgrade
Financial Services Upgrade
Real Estate Upgrade
Sensitive
0.00%
Communication Services Upgrade
Energy Upgrade
Industrials Upgrade
Technology Upgrade
Defensive
95.51%
Consumer Defensive Upgrade
Healthcare Upgrade
Utilities Upgrade
As of June 27, 2022